Congress eyes sunshine on pharma's ties to fast-growing 'stealth' prescribers

Two U.S. senators introduced a bill last week meant to close a loophole in the Sunshine Act--and add a rapidly burgeoning group of healthcare providers to the database of payments from pharma and devicemakers. The bipartisan pair, Sen. Charles Grassley (R-IA) and Sen. Richard Blumenthal (D-CT), want to add "physician assistants, nurse practitioners, and other advance practice nurses" to the Open Payments database, which tracks pharma's gifts and other payments to doctors. PAs and nurses are among a fast-growing group of "stealth" prescribers that drugmakers sometimes overlook in marketing their meds, consultants have said. More from FiercePharmaMarketing

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.